Postal ballot also clears remuneration proposal and new ESOP 2026 scheme, strengthening the company’s leadership and talent retention strategy
Our Global Capability Center (GCC) in Bengaluru drives our major software development initiatives. Complementing this, our Bengaluru facility manufactures antibodies for research and diagnostics. Through these integrated technology and biotech operations, we are proud to contribute to India’s growth story in the life sciences sector.
Eris Lifesciences posts sharp profit surge in FY26 driven by strong diabetes portfolio growth
Company’s FY26 EBITDA rses 20% to Rs. 8,475 crore; Net profit grows 15% amid strong operational performance
Company plans to appeal against CGST order related to alleged inadmissible input tax credit claims
Acquisition of medical equipment distributor aims to strengthen European commercial operations and optimise distribution costs
Collaboration to drive diagnostics exports, tap high-growth regional markets and build scalable commercialization platform
Former Cipla MD & CEO to lead next phase of growth at science-led CDMO platform; Vivek Sharma transitions to advisory role
Huwel’s diagnostic solutions leverage open RT-PCR system
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
